Aridis Pharmaceuticals Inc ARDS:OTCQB

*Data is delayed | Exchange | USD
Last | 10:01 AM EDT
0.0552quote price arrow up+0.0001 (+0.1815%)
Volume
30,078
52 week range
0.05 - 0.54
Loading...
  • Open0.0551
  • Day High0.06
  • Day Low0.0551
  • Prev Close0.0551
  • 52 Week High0.54
  • 52 Week High Date05/31/23
  • 52 Week Low0.05
  • 52 Week Low Date10/17/23

Key Stats

  • Market Cap2.46M
  • Shares Out44.57M
  • 10 Day Average Volume4.22M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-21.26

KEY STATS

  • Open0.0551
  • Day High0.06
  • Day Low0.0551
  • Prev Close0.0551
  • 52 Week High0.54
  • 52 Week High Date05/31/23
  • 52 Week Low0.05
  • 52 Week Low Date10/17/23
  • Market Cap2.46M
  • Shares Out44.57M
  • 10 Day Average Volume4.22M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-21.26

RATIOS/PROFITABILITY

  • EPS (TTM)-0.18
  • P/E (TTM)-0.30
  • Fwd P/E (NTM)-2.76
  • EBITDA (TTM)193.426M
  • ROE (TTM)-1,000.79%
  • Revenue (TTM)22.359M
  • Gross Margin (TTM)11.68%
  • Net Margin (TTM)-5.11%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/20/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aridis Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aridis Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat life-threatening infections. The Company's product pipeline is comprised of fully human mAbs targeting specific pathogens associated with life-threatening bacterial and viral infections, primarily hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP)...
Eric Patzer Ph.D.
Co-Founder, Executive Chairman of the Board
Vu Truong Ph.D.
Chief Executive Officer, Co-Founder, Chief Scientific Officer, Director
Address
983 University Avenue, Bldg. B
Los Gatos, CA
95032
United States

Top Peers

SYMBOLLASTCHG%CHG
OPGN
OpGen Inc
0.4484+0.009+2.0482%
XBIO
Xenetic Biosciences Inc
3.95-0.01-0.14%
GMDAQ
Gamida Cell Ltd
0.0144-0.0021-12.7273%
ENSC
Ensysce Biosciences Inc
0.6099-0.0022-0.3594%
INBS
Intelligent Bio Solutions Inc
2.31-0.03-1.29%